Van Doorn et al. present a valuable synthesis of sFlt-1/PlGF ratios and complement assays in pregnancy-associated thrombotic microangiopathy (TMA).1 I would like to highlight a conceptual issue raised by case COM005 that bears directly on clinical interpretation and bedside management.